Coherus Oncology (CHRS) Tax Rate (2019 - 2023)

Coherus Oncology (CHRS) posted Tax Rate of 0.95% for Q3 2023, down 90.29% sequentially from 9.78% in Q4 2020.

Coherus Oncology (CHRS) Tax Rate (2019 - 2023) Analysis & Trends

Coherus Oncology has reported Tax Rate for 3 years, with the latest figure at 0.95% in Q3 2023.

Quarterly Tax Rate changed N/A year-over-year to 0.95% in Q3 2023, while the trailing twelve-month figure through Dec 2023 was 0.16% (changed N/A YoY) and the FY2024 annual result came in at 0.05%, down 21.0% from the prior year.
Tax Rate eased to 0.95% in Q3 2023 per CHRS's latest filing, from 9.78% in the prior quarter.
Over five years, Tax Rate peaked at 9.78% in Q4 2020 and troughed at 0.22% in Q2 2019.
A 3-year average of 2.85% and a median of 1.91% in 2019 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 493 bps in 2020, down 102 bps in 2020.
Over 3 years, Tax Rate stood at 4.85% in 2019, then surged by 102 bps to 9.78% in 2020, then slumped by 90 bps to 0.95% in 2023.
According to Business Quant data, Tax Rate over the past three periods registered 0.95%, 9.78%, and 0.65% for Q3 2023, Q4 2020, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Coherus Oncology	221.39 Mn	116.08 Mn	10.07 Mn	-

Download Data